CD4 and non-small cell lung carcinoma: In addition, two recent studies have demonstrated that the presence of specific subsets of CD4+ T cells in the peripheral blood of NSCLC patients treated with PD-L1/PD-1 blockade therapy was significantly correlated with better responses.37